Alembic Pharmaceuticals Limited v. GlaxoSmithKline LLC
1:18-cv-01513
Overview
Case Number
1:18-cv-01513
Filing Date
2018-09-28
Status
Terminated
Termination Date
2018-11-27
Court
District Court, D. Delaware (ded)
Presiding Judge
Richard G. Andrews
Nature of Suit
830 Patent
Jurisdiction Type
Federal Question
Cause of Action
35:271 Patent Infringement
Jury Demand
None
Parties
Defendant
GlaxoSmithKline LLC
Represented By
1 Attorneys ListedFarnan LLP
Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301
919 North Market Street, 12th Floor
Plaintiff
Alembic Pharmaceuticals, Inc.
Represented By
1 Attorneys ListedRichards, Layton & Finger, PA
Tel: +1 (302) 651-7705
Richards, Layton & Finger, PA, One Rodney Square
Alembic Pharmaceuticals Limited
Represented By
1 Attorneys ListedRichards, Layton & Finger, PA
Tel: +1 (302) 651-7705
Richards, Layton & Finger, PA, One Rodney Square
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Richard G. Andrews
Docket Entries
COMPLAINT FOR PATENT INFRINGEMENT filed against Glaxo Group Limited, GlaxoSmithKline LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2470666.) - filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A and B, # 2 Civil Cover Sheet)(crb) (Entered: 10/01/2018)
2018-09-28
1
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb) (Entered: 10/01/2018)
2018-09-28
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,637,512 ;9,144,547. (crb) (Entered: 10/01/2018)
2018-09-28
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Alembic Pharmaceuticals, Ltd., Corporate Parent Alembic Global Holdings S/A for Alembic Pharmaceuticals, Inc. filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. (crb) (Entered: 10/01/2018)
2018-09-28
1